Author： Schwarb F.P. W. Smith E. Haigh J.M. Surber C.
Publisher： Elsevier
ISSN： 0939-6411
Source： European Journal of Pharmaceutics and Biopharmaceutics, Vol.47, Iss.3, 1999-05, pp. : 261-267
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Corticosteroid-Induced Osteoporosis: Detection and Management
Drug Safety, Vol. 24, Iss. 8, 2001-01 ,pp. :
Access to resources
Recommend
Recommendations for preventing, treating corticosteroid-induced bone loss
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. :
Corticosteroid-induced osteoporosis: prescribing pattern varies in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. :
Corticosteroid-Induced Adverse Psychiatric Effects: Incidence, Diagnosis and Management
By Patten S.B.
Drug Safety, Vol. 22, Iss. 2, 2000-02 ,pp. :